Idiopathic polypoidal choroidal vasculopathy
Information
- Disease name
- Idiopathic polypoidal choroidal vasculopathy
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT02397954 | Completed | Phase 2 | A Study to Establish the Safety and Tolerability of Zimura® (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) | March 2015 | October 2015 |
NCT03374670 | Withdrawn | Phase 2 | ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) | November 2018 | December 2019 |
- MedGen concept unique identifier (MedGen Concept name)
- C0730364
- MedGen unique identifier (MedGen Concept name)
- 676553